PendraCare Group develops, manufactures and sells innovative cardiology catheter solutions and provides design, development and manufacturing services to other global OEM’s
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Aurobindo Pharma’s US formulations revenue slipped 1.9% on a year-on-year basis to Rs. 3,488 crore
Subscribe To Our Newsletter & Stay Updated
